Ebr Systems (EBRCZ) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
EBR Systems, Inc.  (OTC: EBRCZ)
 

Ebr Systems Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ebr Systems, Inc. inventory turnover ratio, the Ebr Systems, Inc.'s ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 0.3 in the first quarter 2026, a new company high. Average inventory processing period, for the Ebr Systems in Mar 31 2026 quarter, has decreased to 1217 days, compare to 2607 days, in the Dec 31 2025 quarter.

Within Healthcare sector EBR Systems, Inc. achieved the highest inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the fourth quarter 2025, to 1902.

EBRCZ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ebr Systems, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EBRCZ Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 228.33 % 891.3 % 708.87 % - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.3 0.14 0.07 0.03 -
EBRCZ's Total Ranking # 1902 # # # #
Average inventory processing period 1218 2699 5111 13309 -
Seq. Inventory Growth 12.35 % 42.31 % 88.73 % 8.81 % 239.21 %
Seq. Cost of Sales Growth 189.13 % 161.2 % 238.1 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market # 1902

Inventory Turnover Ratio Statistics
High Average Low
0.3 0.13 0.03
(Mar 31 2026)   (Jun 30 2025)



EBRCZ Company Profile >> Back to EBRCZ Efficiency Comparisons >> Compare EBRCZ Inventory Turnover Ratio to its Competitors

Financial Statements
Ebr Systems's Inventories $ 15 Millions Visit EBRCZ's Balance sheet
Ebr Systems's Cost of Revenues TTM $ 3 Millions Visit EBRCZ's Income Statement
What are EBRCZ's Sales? Visit EBRCZ's Sales by Segment

Other Inventory Turnover Ratios
Ebr Systems's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EBRCZ's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EBRCZ's Competitors
Inventory Turnover Ratio for EBRCZ's Suppliers
Inventory Turnover Ratio for EBRCZ's Customers

You may also want to know
EBRCZ's Sales Growth Rates EBRCZ's Pe Price to earnings ratio EBRCZ's Receivables Turnover Ratio EBRCZ's Stock Quote
EBRCZ's Net Income Growth Rates EBRCZ's Ps Price to Sales ratio EBRCZ's Sales per Employee EBRCZ's Asset Turnover Ratio
EBRCZ's Net Margin EBRCZ's Pb Price to Book ratio EBRCZ's Financial Strength Ratios EBRCZ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Gyre Therapeutics Inc   0.59 $ 5.749  Millions$ 10  Millions
Biomarin Pharmaceutical Inc  0.57 $ 760.883  Millions$ 1,324  Millions
Envue Medical Inc   0.57 $ 0.708  Millions$ 1  Millions
Verastem Inc   0.55 $ 0.977  Millions$ 2  Millions
Heron Therapeutics Inc   0.52 $ 43.000  Millions$ 82  Millions
Orthopediatrics Corp  0.49 $ 64.000  Millions$ 130  Millions
Jaguar Health Inc   0.47 $ 4.417  Millions$ 9  Millions
X4 Pharmaceuticals Inc  0.40 $ 1.639  Millions$ 4  Millions
Clene Inc   0.40 $ 0.023  Millions$ 0  Millions
Outlook Therapeutics Inc   0.40 $ 1.408  Millions$ 4  Millions
Co diagnostics Inc   0.40 $ 0.399  Millions$ 1  Millions
Regeneron Pharmaceuticals Inc   0.39 $ 1,248.700  Millions$ 3,191  Millions
Soleno Therapeutics Inc  0.38 $ 3.898  Millions$ 10  Millions
Guided Therapeutics Inc   0.37 $ 0.196  Millions$ 1  Millions
Alpha Cognition Inc.  0.31 $ 1.300  Millions$ 4  Millions
Aditxt Inc   0.31 $ 0.012  Millions$ 0  Millions
Nexalin Technology Inc   0.31 $ 0.050  Millions$ 0  Millions
EBR Systems, Inc.  0.30 $ 3.305  Millions$ 11  Millions
Vystar Corporation  0.27 $ 0.017  Millions$ 0  Millions
Immunitybio inc   0.25 $ 0.933  Millions$ 4  Millions
Adagio Medical Holdings inc   0.23 $ 0.431  Millions$ 2  Millions
Agios Pharmaceuticals Inc   0.20 $ 6.579  Millions$ 33  Millions
Biocorrx Inc   0.17 $ 0.025  Millions$ 0  Millions
Bioadaptives Inc   0.17 $ 0.007  Millions$ 0  Millions
Femasys Inc   0.16 $ 0.914  Millions$ 6  Millions
Yubo International Biotech Limited  0.14 $ 0.004  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.05 $ 1.118  Millions$ 21  Millions
Ptc Therapeutics inc   0.05 $ 3.100  Millions$ 60  Millions

Date modified: 2026-08-30T11:48:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.